Showing results (61-70 of 172) with videos related to
Sort By:
Pageof 18
British Journal of Haematology|September 4, 2008
Phase II multicenter study of oblimersen sodium, a Bcl-2 antisense oligonucleotide, in combination with rituximab in patients with recurrent B-cell non-Hodgkin lymphomaBarbara Pro, Brian Leber, Mitchell Smith, et al.Clinical Trials (London, England)|May 8, 2016
Response assessment in lymphoma: Concordance between independent central review and local evaluation in a clinical trial settingAjay K Gopal, Barbara Pro, Joseph M Connors, et al.Leukemia & Lymphoma|March 22, 2024
Phase II study of the novel antifolate agent pralatrexate in combination with the histone deacetylase inhibitor romidepsin for the treatment of patients with mature T-cell lymphomaYun Kyoung Ryu Tiger, Salvia Jain, Stefan K Barta, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 4, 2003
Nonablative allogeneic stem-cell transplantation for advanced/recurrent mantle-cell lymphomaIssa F Khouri, Ming-S Lee, Rima M Saliba, et al.Blood Advances|June 16, 2023
Multicenter phase 2 study of romidepsin plus lenalidomide for previously untreated peripheral T-cell lymphomaJia Ruan, Jasmine Zain, Brett Palmer, et al.Leukemia & Lymphoma|March 8, 2017
Romidepsin is effective and well tolerated in older patients with peripheral T-cell lymphoma: analysis of two phase II trialsAndrei Shustov, Bertrand Coiffier, Steven Horwitz, et al.Cancer|June 16, 2010
Marginal zone lymphomas: factors that affect the final outcomeAli Mazloom, L Jeffrey Medeiros, Peter W McLaughlin, et al.Cancer|July 13, 2002
International prognostic index-based outcomes for diffuse large B-cell lymphomasRichard B Wilder, Maria A Rodriguez, L Jeffrey Medeiros, et al.Clinical Lymphoma, Myeloma & Leukemia|May 1, 2012
Pralatrexate is an effective treatment for relapsed or refractory transformed mycosis fungoides: a subgroup efficacy analysis from the PROPEL studyFrancine Foss, Steven M Horwitz, Bertrand Coiffier, et al.Blood Neoplasia|September 15, 2025
Retrospective evaluation of R-EPOCH in the frontline treatment of adult patients with PTLD after solid organ transplantBrian Cuzzo, Maegan Ford, Saagar Jain, et al.Pageof 18